推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 工信部27日發(fā)布通知，決定組織實(shí)施2015年工業(yè)轉(zhuǎn)型升級重點(diǎn)項目。根據(jù)通知，2015年轉(zhuǎn)型升級資金重點(diǎn)針對智能制造和“互聯(lián)網(wǎng)+”行動支撐保障能力、綠色制造、中藥材提升與保障、工業(yè)強(qiáng)基等4大重點(diǎn)領(lǐng)域和中小企業(yè)服務(wù)體系重點(diǎn)專項，共實(shí)施20項任務(wù)73個方向。
其中，中藥材提升與保障領(lǐng)域主要涉及的項目包括中藥材生產(chǎn)基地建設(shè)、中藥材生產(chǎn)服務(wù)與供應(yīng)保障體系建設(shè)。
機(jī)構(gòu)表示，中醫(yī)藥行業(yè)將迎來重大戰(zhàn)略機(jī)遇，對整個中藥板塊形成長期實(shí)質(zhì)性利好。中醫(yī)藥行業(yè)傳統(tǒng)老字號企業(yè)有望在政策支持下得到傳承并發(fā)揚(yáng)光大，相關(guān)標(biāo)的有云南白藥、同仁堂、片仔癀、東阿阿膠等；中藥現(xiàn)代化龍頭企業(yè)有望從規(guī)范化經(jīng)營、規(guī)?；l(fā)展的趨勢中持續(xù)受益，相關(guān)標(biāo)的有天士力、康緣藥業(yè)、以嶺藥業(yè)、昆明制藥等。
同時，建議關(guān)注中藥材種植、流通領(lǐng)域、擁有貴細(xì)藥材資源的中藥材領(lǐng)軍企業(yè)、布局中藥材互聯(lián)網(wǎng)平臺和供需數(shù)據(jù)信息的上市公司及有中藥材質(zhì)量檢驗(yàn)檢測能力的第三方機(jī)構(gòu)，如康美藥業(yè)、益盛藥業(yè)、同仁堂等。
